期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Effect of 5-HT1 agonist (sumatriptan) on anorectal function in irritable bowel syndrome patients 被引量:4
1
作者 Agata Mulak leszek paradowski 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第10期1591-1596,共6页
AIM: To evaluate the effect of sumatriptan, a selective 5-HT1 agonist, on anorectal function in irritable bowel syndrome (IBS) patients. METHODS: Twenty-two IBS patients selected according to the Rome II criteria ... AIM: To evaluate the effect of sumatriptan, a selective 5-HT1 agonist, on anorectal function in irritable bowel syndrome (IBS) patients. METHODS: Twenty-two IBS patients selected according to the Rome II criteria (F 15, M 7; mean age 29.3±6.8, range 22-44 years) were examined. The study was blind, randomized and placebo-controlled with a crossover design. Anorectal manometry and rectal balloon distension test were performed before and after the administration of placebo and sumatriptan. RESULTS: The administration of sumatriptan caused a significant increase in the resting anal canal pressure from 9.2±2.0 kPa to 13.1±3.3 kPa (P〈0.0001) connected with the increase in the anal sphincter length and high pressure zone. After sumatriptan injection a remarkable increase in the threshold for the first sensation from 27±9 mL to 34±12 mL (P〈0.05) and urge sensation from 61±19 mL to 68±18 mL (P〈0.01) was observed. Sumatriptan did not affect either the volume evoking the rectoanal inhibitory reflex or the results of the straining test. CONCLUSION: 5-HT1 receptors participate in the regulation of anorectal function. Elucidation of the role of 5-HT1 receptors in the pathophysiological mechanisms of IBS may have some therapeutic implications. 展开更多
关键词 SUMATRIPTAN 5-HT receptors Irritable bowel syndrome Anorectal function
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部